Sherbrooke Park Advisers LLC Cassava Sciences Inc Transaction History
Sherbrooke Park Advisers LLC
- $313 Billion
- Q4 2024
A detailed history of Sherbrooke Park Advisers LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 49,584 shares of SAVA stock, worth $81,813. This represents 0.04% of its overall portfolio holdings.
Number of Shares
49,584Holding current value
$81,813% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding SAVA
# of Institutions
187Shares Held
16.3MCall Options Held
3.49MPut Options Held
8.08M-
Black Rock Inc. New York, NY3.22MShares$5.31 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.51MShares$4.15 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.01MShares$1.66 Million0.0% of portfolio
-
State Street Corp Boston, MA997KShares$1.64 Million0.0% of portfolio
-
Ubs Group Ag931KShares$1.54 Million0.0% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $66.2M
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...